Skip to main content
Erschienen in: Cancer Causes & Control 12/2015

01.12.2015 | Original paper

Post-diagnosis adiposity and survival among breast cancer patients: influence of breast cancer subtype

verfasst von: Xuezheng Sun, Hazel B. Nichols, Whitney Robinson, Mark E. Sherman, Andrew F. Olshan, Melissa A. Troester

Erschienen in: Cancer Causes & Control | Ausgabe 12/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Adiposity has been linked with increased breast cancer risk and mortality. It is established that etiologic associations for adiposity vary by tumor subtype, but the influence of adiposity on subtype-specific survival is unknown.

Methods

Study participants were 1,109 invasive breast cancer participants in the population-based Carolina Breast Cancer Study, diagnosed between 1993 and 2001, and with tissue blocks available for immunohistochemical subtyping. General and central adiposities were assessed by body mass index (BMI) and waist-to-hip ratio (WHR), respectively, based on in-person measurements after diagnosis. Vital status as of 2011 was determined using the National Death Index (median follow-up = 13.5 years). Cox proportional hazards models were used to calculate hazard ratios (HRs) and 95 % confidence intervals (CIs) for breast cancer (BC)-specific and all-cause mortalities.

Results

Among all patients, high WHR (≥0.84), but not BMI, was associated with all-cause mortality (adjusted HR 1.50, 95 % CI 1.11–2.05, <0.77 as reference). No significant association between adiposity and BC-specific mortality was detected, although there was a suggestion of increased mortality risk among high-BMI (≥30 kg/m2) patients with basal-like tumors (adjusted HR 2.44, 95 % CI 0.97–6.12, <25 kg/m2 as reference). Quantitative differences in all-cause mortality were observed by subtype, with BMI associated with basal-like mortality and WHR associated with luminal mortality. The associations were attenuated by tumor characteristics.

Conclusions

Our study confirms the association of adiposity and unfavorable overall survival in breast cancer patients and suggests that this association may vary by intrinsic subtype and adiposity measure.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Chan DS, Vieira AR, Aune D et al (2014) Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol 25:1901–1914PubMedCentralCrossRefPubMed Chan DS, Vieira AR, Aune D et al (2014) Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol 25:1901–1914PubMedCentralCrossRefPubMed
2.
Zurück zum Zitat Roberts DL, Dive C, Renehan AG (2010) Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med 61:301–316CrossRefPubMed Roberts DL, Dive C, Renehan AG (2010) Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med 61:301–316CrossRefPubMed
3.
Zurück zum Zitat Rose DP, Komninou D, Stephenson GD (2004) Obesity, adipocytokines, and insulin resistance in breast cancer. Obes Rev 5:153–165CrossRefPubMed Rose DP, Komninou D, Stephenson GD (2004) Obesity, adipocytokines, and insulin resistance in breast cancer. Obes Rev 5:153–165CrossRefPubMed
4.
Zurück zum Zitat Gilbert CA, Slingerland JM (2013) Cytokines, obesity, and cancer: new insights on mechanisms linking obesity to cancer risk and progression. Annu Rev Med 64:45–57CrossRefPubMed Gilbert CA, Slingerland JM (2013) Cytokines, obesity, and cancer: new insights on mechanisms linking obesity to cancer risk and progression. Annu Rev Med 64:45–57CrossRefPubMed
5.
Zurück zum Zitat Wang Y, Beydoun MA (2007) The obesity epidemic in the United States—gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev 29:6–28CrossRefPubMed Wang Y, Beydoun MA (2007) The obesity epidemic in the United States—gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev 29:6–28CrossRefPubMed
6.
Zurück zum Zitat Baskin ML, Ard J, Franklin F, Allison DB (2005) Prevalence of obesity in the United States. Obes Rev 6:5–7CrossRefPubMed Baskin ML, Ard J, Franklin F, Allison DB (2005) Prevalence of obesity in the United States. Obes Rev 6:5–7CrossRefPubMed
7.
Zurück zum Zitat Lu Y, Ma H, Malone KE et al (2011) Obesity and survival among black women and white women 35 to 64 years of age at diagnosis with invasive breast cancer. J Clin Oncol 29:3358–3365PubMedCentralCrossRefPubMed Lu Y, Ma H, Malone KE et al (2011) Obesity and survival among black women and white women 35 to 64 years of age at diagnosis with invasive breast cancer. J Clin Oncol 29:3358–3365PubMedCentralCrossRefPubMed
8.
Zurück zum Zitat Enger SM, Bernstein L (2004) Exercise activity, body size and premenopausal breast cancer survival. Br J Cancer 90:2138–2141PubMedCentralPubMed Enger SM, Bernstein L (2004) Exercise activity, body size and premenopausal breast cancer survival. Br J Cancer 90:2138–2141PubMedCentralPubMed
9.
Zurück zum Zitat Kwan ML, Kushi LH, Weltzien E et al (2009) Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors. Breast Cancer Res 11:R31PubMedCentralCrossRefPubMed Kwan ML, Kushi LH, Weltzien E et al (2009) Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors. Breast Cancer Res 11:R31PubMedCentralCrossRefPubMed
10.
Zurück zum Zitat Yang XR, Sherman ME, Rimm DL et al (2007) Differences in risk factors for breast cancer molecular subtypes in a population-based study. Cancer Epidemiol Biomark Prev 16:439–443CrossRef Yang XR, Sherman ME, Rimm DL et al (2007) Differences in risk factors for breast cancer molecular subtypes in a population-based study. Cancer Epidemiol Biomark Prev 16:439–443CrossRef
11.
Zurück zum Zitat Lin NU, Vanderplas A, Hughes ME et al (2012) Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network. Cancer 118:5463–5472PubMedCentralCrossRefPubMed Lin NU, Vanderplas A, Hughes ME et al (2012) Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network. Cancer 118:5463–5472PubMedCentralCrossRefPubMed
12.
Zurück zum Zitat Gaudet MM, Press MF, Haile RW et al (2011) Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger. Breast Cancer Res Treat 130:587–597PubMedCentralCrossRefPubMed Gaudet MM, Press MF, Haile RW et al (2011) Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger. Breast Cancer Res Treat 130:587–597PubMedCentralCrossRefPubMed
13.
Zurück zum Zitat Prat A, Adamo B, Cheang MC, Anders CK, Carey LA, Perou CM (2013) Molecular characterization of basal-like and non-basal-like triple-negative breast cancer. Oncologist 18:123–133PubMedCentralCrossRefPubMed Prat A, Adamo B, Cheang MC, Anders CK, Carey LA, Perou CM (2013) Molecular characterization of basal-like and non-basal-like triple-negative breast cancer. Oncologist 18:123–133PubMedCentralCrossRefPubMed
14.
Zurück zum Zitat Perou CM, Sorlie T, Eisen MB et al (2000) Molecular portraits of human breast tumours. Nature 406:747–752CrossRefPubMed Perou CM, Sorlie T, Eisen MB et al (2000) Molecular portraits of human breast tumours. Nature 406:747–752CrossRefPubMed
15.
Zurück zum Zitat Carey LA, Perou CM, Livasy CA et al (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295:2492–2502CrossRefPubMed Carey LA, Perou CM, Livasy CA et al (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295:2492–2502CrossRefPubMed
16.
Zurück zum Zitat Protani M, Coory M, Martin JH (2010) Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat 123:627–635CrossRefPubMed Protani M, Coory M, Martin JH (2010) Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat 123:627–635CrossRefPubMed
18.
Zurück zum Zitat Trivers KF, Lund MJ, Porter PL et al (2009) The epidemiology of triple-negative breast cancer, including race. Cancer Causes Control 20:1071–1082CrossRefPubMed Trivers KF, Lund MJ, Porter PL et al (2009) The epidemiology of triple-negative breast cancer, including race. Cancer Causes Control 20:1071–1082CrossRefPubMed
19.
Zurück zum Zitat Newman B, Moorman PG, Millikan R et al (1995) The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology. Breast Cancer Res Treat 35:51–60CrossRefPubMed Newman B, Moorman PG, Millikan R et al (1995) The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology. Breast Cancer Res Treat 35:51–60CrossRefPubMed
20.
Zurück zum Zitat Weinberg CR, Wacholder S (1990) The design and analysis of case–control studies with biased sampling. Biometrics 46:963–975CrossRefPubMed Weinberg CR, Wacholder S (1990) The design and analysis of case–control studies with biased sampling. Biometrics 46:963–975CrossRefPubMed
21.
Zurück zum Zitat Prat A, Cheang MC, Martin M et al (2013) Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal A breast cancer. J Clin Oncol 31:203–209PubMedCentralCrossRefPubMed Prat A, Cheang MC, Martin M et al (2013) Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal A breast cancer. J Clin Oncol 31:203–209PubMedCentralCrossRefPubMed
22.
Zurück zum Zitat Goldhirsch A, Winer EP, Coates AS et al (2013) Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol 24:2206–2223PubMedCentralCrossRefPubMed Goldhirsch A, Winer EP, Coates AS et al (2013) Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol 24:2206–2223PubMedCentralCrossRefPubMed
23.
Zurück zum Zitat Bastien RR, Rodriguez-Lescure A, Ebbert MT et al (2012) PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers. BMC Med Genomics 5:44-8794-5-44CrossRef Bastien RR, Rodriguez-Lescure A, Ebbert MT et al (2012) PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers. BMC Med Genomics 5:44-8794-5-44CrossRef
24.
Zurück zum Zitat Anderson WF, Rosenberg PS, Prat A, Perou CM, Sherman ME (2014) How many etiological subtypes of breast cancer: Two, three, four, or more? J Natl Cancer Inst. doi:10.1093/jnci/dju165 Anderson WF, Rosenberg PS, Prat A, Perou CM, Sherman ME (2014) How many etiological subtypes of breast cancer: Two, three, four, or more? J Natl Cancer Inst. doi:10.​1093/​jnci/​dju165
25.
Zurück zum Zitat Flegal KM, Carroll MD, Ogden CL, Curtin LR (2010) Prevalence and trends in obesity among US adults, 1999–2008. JAMA 303:235–241CrossRefPubMed Flegal KM, Carroll MD, Ogden CL, Curtin LR (2010) Prevalence and trends in obesity among US adults, 1999–2008. JAMA 303:235–241CrossRefPubMed
26.
Zurück zum Zitat Soerjomataram I, Louwman MW, Ribot JG, Roukema JA, Coebergh JW (2008) An overview of prognostic factors for long-term survivors of breast cancer. Breast Cancer Res Treat 107:309–330PubMedCentralCrossRefPubMed Soerjomataram I, Louwman MW, Ribot JG, Roukema JA, Coebergh JW (2008) An overview of prognostic factors for long-term survivors of breast cancer. Breast Cancer Res Treat 107:309–330PubMedCentralCrossRefPubMed
27.
Zurück zum Zitat Vazquez G, Duval S, Jacobs DR Jr, Silventoinen K (2007) Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis. Epidemiol Rev 29:115–128CrossRefPubMed Vazquez G, Duval S, Jacobs DR Jr, Silventoinen K (2007) Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis. Epidemiol Rev 29:115–128CrossRefPubMed
28.
Zurück zum Zitat George SM, Bernstein L, Smith AW et al (2014) Central adiposity after breast cancer diagnosis is related to mortality in the Health, Eating, Activity, and Lifestyle study. Breast Cancer Res Treat 146:647–655CrossRefPubMed George SM, Bernstein L, Smith AW et al (2014) Central adiposity after breast cancer diagnosis is related to mortality in the Health, Eating, Activity, and Lifestyle study. Breast Cancer Res Treat 146:647–655CrossRefPubMed
29.
Zurück zum Zitat Borugian MJ, Sheps SB, Kim-Sing C et al (2003) Waist-to-hip ratio and breast cancer mortality. Am J Epidemiol 158:963–968CrossRefPubMed Borugian MJ, Sheps SB, Kim-Sing C et al (2003) Waist-to-hip ratio and breast cancer mortality. Am J Epidemiol 158:963–968CrossRefPubMed
30.
Zurück zum Zitat Mazzarella L, Disalvatore D, Bagnardi V et al (2013) Obesity increases the incidence of distant metastases in oestrogen receptor-negative human epidermal growth factor receptor 2-positive breast cancer patients. Eur J Cancer 49:3588–3597CrossRefPubMed Mazzarella L, Disalvatore D, Bagnardi V et al (2013) Obesity increases the incidence of distant metastases in oestrogen receptor-negative human epidermal growth factor receptor 2-positive breast cancer patients. Eur J Cancer 49:3588–3597CrossRefPubMed
31.
Zurück zum Zitat Mowad R, Chu QD, Li BD, Burton GV, Ampil FL, Kim RH (2013) Does obesity have an effect on outcomes in triple-negative breast cancer? J Surg Res 184:253–259CrossRefPubMed Mowad R, Chu QD, Li BD, Burton GV, Ampil FL, Kim RH (2013) Does obesity have an effect on outcomes in triple-negative breast cancer? J Surg Res 184:253–259CrossRefPubMed
32.
Zurück zum Zitat Turkoz FP, Solak M, Petekkaya I et al (2013) The prognostic impact of obesity on molecular subtypes of breast cancer in premenopausal women. J BUON 18:335–341PubMed Turkoz FP, Solak M, Petekkaya I et al (2013) The prognostic impact of obesity on molecular subtypes of breast cancer in premenopausal women. J BUON 18:335–341PubMed
33.
Zurück zum Zitat Ademuyiwa FO, Groman A, O’Connor T, Ambrosone C, Watroba N, Edge SB (2011) Impact of body mass index on clinical outcomes in triple-negative breast cancer. Cancer 117:4132–4140CrossRefPubMed Ademuyiwa FO, Groman A, O’Connor T, Ambrosone C, Watroba N, Edge SB (2011) Impact of body mass index on clinical outcomes in triple-negative breast cancer. Cancer 117:4132–4140CrossRefPubMed
34.
Zurück zum Zitat Dawood S, Lei X, Litton JK, Buchholz TA, Hortobagyi GN, Gonzalez-Angulo AM (2012) Impact of body mass index on survival outcome among women with early stage triple-negative breast cancer. Clin Breast Cancer 12:364–372CrossRefPubMed Dawood S, Lei X, Litton JK, Buchholz TA, Hortobagyi GN, Gonzalez-Angulo AM (2012) Impact of body mass index on survival outcome among women with early stage triple-negative breast cancer. Clin Breast Cancer 12:364–372CrossRefPubMed
35.
Zurück zum Zitat Sparano JA, Wang M, Zhao F et al (2012) Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer. Cancer 118:5937–5946PubMedCentralCrossRefPubMed Sparano JA, Wang M, Zhao F et al (2012) Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer. Cancer 118:5937–5946PubMedCentralCrossRefPubMed
36.
Zurück zum Zitat Robinson PJ, Bell RJ, Davis SR (2014) Obesity is associated with a poorer prognosis in women with hormone receptor positive breast cancer. Maturitas 79:279–286CrossRefPubMed Robinson PJ, Bell RJ, Davis SR (2014) Obesity is associated with a poorer prognosis in women with hormone receptor positive breast cancer. Maturitas 79:279–286CrossRefPubMed
37.
Zurück zum Zitat Abrahamson PE, Gammon MD, Lund MJ et al (2006) General and abdominal obesity and survival among young women with breast cancer. Cancer Epidemiol Biomark Prev 15:1871–1877CrossRef Abrahamson PE, Gammon MD, Lund MJ et al (2006) General and abdominal obesity and survival among young women with breast cancer. Cancer Epidemiol Biomark Prev 15:1871–1877CrossRef
38.
Zurück zum Zitat Kawai M, Minami Y, Nishino Y, Fukamachi K, Ohuchi N, Kakugawa Y (2012) Body mass index and survival after breast cancer diagnosis in Japanese women. BMC Cancer 12:149-2407-12-149CrossRef Kawai M, Minami Y, Nishino Y, Fukamachi K, Ohuchi N, Kakugawa Y (2012) Body mass index and survival after breast cancer diagnosis in Japanese women. BMC Cancer 12:149-2407-12-149CrossRef
39.
Zurück zum Zitat Dignam JJ, Wieand K, Johnson KA, Fisher B, Xu L, Mamounas EP (2003) Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer. J Natl Cancer Inst 95:1467–1476CrossRefPubMed Dignam JJ, Wieand K, Johnson KA, Fisher B, Xu L, Mamounas EP (2003) Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer. J Natl Cancer Inst 95:1467–1476CrossRefPubMed
40.
Zurück zum Zitat Hernán M, Taubman S (2008) Does obesity shorten life&quest; the importance of well-defined interventions to answer causal questions. Int J Obes 32:S8–S14CrossRef Hernán M, Taubman S (2008) Does obesity shorten life&quest; the importance of well-defined interventions to answer causal questions. Int J Obes 32:S8–S14CrossRef
41.
Zurück zum Zitat Kwan ML, Kroenke CH, Sweeney C et al (2015) Association of high obesity with PAM50 breast cancer intrinsic subtypes and gene expression. BMC Cancer 15:278-015-1263-4CrossRef Kwan ML, Kroenke CH, Sweeney C et al (2015) Association of high obesity with PAM50 breast cancer intrinsic subtypes and gene expression. BMC Cancer 15:278-015-1263-4CrossRef
42.
Zurück zum Zitat Lee MJ, Wu Y, Fried SK (2013) Adipose tissue heterogeneity: implication of depot differences in adipose tissue for obesity complications. Mol Aspects Med 34:1–11PubMedCentralCrossRefPubMed Lee MJ, Wu Y, Fried SK (2013) Adipose tissue heterogeneity: implication of depot differences in adipose tissue for obesity complications. Mol Aspects Med 34:1–11PubMedCentralCrossRefPubMed
43.
Zurück zum Zitat Tchernof A, Despres JP (2013) Pathophysiology of human visceral obesity: an update. Physiol Rev 93:359–404CrossRefPubMed Tchernof A, Despres JP (2013) Pathophysiology of human visceral obesity: an update. Physiol Rev 93:359–404CrossRefPubMed
44.
Zurück zum Zitat Savastano S, Di Somma C, Belfiore A et al (2006) Growth hormone status in morbidly obese subjects and correlation with body composition. J Endocrinol Invest 29:536–543CrossRefPubMed Savastano S, Di Somma C, Belfiore A et al (2006) Growth hormone status in morbidly obese subjects and correlation with body composition. J Endocrinol Invest 29:536–543CrossRefPubMed
45.
Zurück zum Zitat Bruning PF, Bonfrer JM, Hart AA et al (1992) Body measurements, estrogen availability and the risk of human breast cancer: a case–control study. Int J Cancer 51:14–19CrossRefPubMed Bruning PF, Bonfrer JM, Hart AA et al (1992) Body measurements, estrogen availability and the risk of human breast cancer: a case–control study. Int J Cancer 51:14–19CrossRefPubMed
46.
Zurück zum Zitat Lee SW, Jo HH, Kim MR, You YO, Kim JH (2012) Association between metabolic syndrome and serum leptin levels in postmenopausal women. J Obstet Gynaecol 32:73–77CrossRefPubMed Lee SW, Jo HH, Kim MR, You YO, Kim JH (2012) Association between metabolic syndrome and serum leptin levels in postmenopausal women. J Obstet Gynaecol 32:73–77CrossRefPubMed
47.
Zurück zum Zitat Robinson WR, Tse CK, Olshan AF, Troester MA (2014) Body size across the life course and risk of premenopausal and postmenopausal breast cancer in Black women, the Carolina Breast Cancer Study, 1993–2001. Cancer Causes Control 25:1101–1117PubMedCentralCrossRefPubMed Robinson WR, Tse CK, Olshan AF, Troester MA (2014) Body size across the life course and risk of premenopausal and postmenopausal breast cancer in Black women, the Carolina Breast Cancer Study, 1993–2001. Cancer Causes Control 25:1101–1117PubMedCentralCrossRefPubMed
48.
49.
Zurück zum Zitat Ades F, Zardavas D, Bozovic-Spasojevic I et al (2014) Luminal B breast cancer: molecular characterization, clinical management, and future perspectives. J Clin Oncol 32:2794–2803CrossRefPubMed Ades F, Zardavas D, Bozovic-Spasojevic I et al (2014) Luminal B breast cancer: molecular characterization, clinical management, and future perspectives. J Clin Oncol 32:2794–2803CrossRefPubMed
Metadaten
Titel
Post-diagnosis adiposity and survival among breast cancer patients: influence of breast cancer subtype
verfasst von
Xuezheng Sun
Hazel B. Nichols
Whitney Robinson
Mark E. Sherman
Andrew F. Olshan
Melissa A. Troester
Publikationsdatum
01.12.2015
Verlag
Springer International Publishing
Erschienen in
Cancer Causes & Control / Ausgabe 12/2015
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-015-0673-6

Weitere Artikel der Ausgabe 12/2015

Cancer Causes & Control 12/2015 Zur Ausgabe

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.